'A leukin to the future': is low serum interleukin-2 (IL-2) a predictive biomarker for postoperative atrial
Callum J Quinn1,2, Epiphany S Velasco1,2, Xander H T Wehrens1,2,3,4,5,6
1Cardiovascular Research Institute, Houston, TX 77030, USA.
Abstract:
The stubborn incidence of PoAF requires equally stubborn inroads to find novel regulatory proteins and/or trustworthy biomarkersz. This useful study by Cozac et al. [9] further establishes IL-2 as an important, yet poorly understood protein in the onset of PoAF and sets a solid basis for future investigations in the clinic and using innovative rodent models.
More Related Videos
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
09:00High Throughput Sequential ELISA for Validation of Biomarkers of Acute Graft-Versus-Host Disease
Published on: October 31, 2012